Neuronal degeneration leading to visual impairment or blindness remains a critical challenge in human health. Unlike humans, ...
Eye diseases often develop asymptomatically for many years. ICTER scientists have developed the f-ORG technique, which ...
Bardet-Biedl syndrome (BBS) is a ciliopathy that leads to progressive blindness due to degeneration of cone photoreceptors, but the mechanisms behind this are not well understood. The syndrome is ...
Berlin: Bayer AG and BlueRock Therapeutics LP, a clinical-stage cell therapy company and wholly owned subsidiary of Bayer AG, ...
Neurotech Pharma's cell therapy Encelto has become the first FDA-approved treatment for idiopathic macular telangiectasia ...
Zervimesine is an investigational oral, once-daily pill being developed for the treatment of CNS diseases, including ...